Nicotine Pouch Unit Sales in the US From 2016 to 2020

CDC has released the following tobacco-related publication in the journal, JAMA.

Nicotine Pouch Unit Sales in the US from 2016 to 2020

Manufacturers are currently marketing nicotine pouches and e-cigarettes with synthetic nicotine in the US.  Whether derived from tobacco plants or synthetically developed in a laboratory, nicotine is an addictive drug with known adverse consequences for fetal development and adolescent brain development.

Given public health considerations, synthetic nicotine products warrant urgent attention from policy makers, clinicians, and researchers.  Sufficient scientific evidence about nicotine’s harmful effects exists to caution young people and pregnant adults against use of synthetic nicotine and to justify inclusion of synthetic nicotine products in existing regulatory efforts.

The article is available online at:


Upcoming Events

Attending any of these upcoming events? Have other events to share? Let us know! Email us at NNN@ITCMI.ORG to share your event information or to get on our list serve for event updates.


Indigenous Cancer Prevention Webinar Series:  Salish Cancer Center of The Puyallup Tribe of Indians | LEARN MORE

Breast Cancer Awareness Month | LEARN MORE

Part 3:  Lung Cancer Disparities:  Addressing Gaps and Opportunities to Improve Health Outcomes and Health Equity Among Low-Income Populations | LEARN MORE AND REGISTER

Cancer Prevention in Indigenous Communities:  Screening to Follow Up | LEARN MORE AND REGISTER

Indigenous Cancer Prevention Webinar Series:  Reclaiming our Tobacco through Tobacco Policy Passing of the Navajo Nitch' Éí Bee Ííná -- Air is Life Act of 2021 | LEARN MORE AND REGISTER

Native American Heritage Month | LEARN MORE